[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-370467-105":59,"doc-detail-370467-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","transcription-factor-p73-is-a-predictor-of-platinum-resistance-and-promotes-aggressive-epithelial-ovarian-cancers","Transcription Factor p73 Is a Predictor of Platinum Resistance and Promotes Aggressive Epithelial Ovarian Cancers","","Resistance to platinum-based chemotherapy remains a major clinical challenge in ovarian cancers, with predictive biomarkers and effective therapies still unmet. This study evaluates p73, a p53-family transcription factor, focusing on its involvement in DNA repair, proliferation, invasion, and apoptosis. p73 protein expression was assessed in 278 ovarian cancers, while TP73 transcripts were analyzed in public datasets and TCGA. Findings link high p73 with higher grade, advanced stage, and poorer progression-free survival. Mechanistic experiments show p73 overexpression increases aggressive phenotypes and DNA repair capacity, while p73 deletion enhances cisplatin sensitivity via apoptosis and cell-cycle arrest, supporting p73 as a biomarker and therapeutic target.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/transcription-factor-p73-is-a-predictor-of-platinum-resistance-and-promotes-aggressive-epithelial-ovarian-cancers/370467/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/transcription-factor-p73-is-a-predictor-of-platinum-resistance-and-promotes-aggressive-epithelial-ovarian-cancers/370467.png","ImageObject",300,407,{"name":92,"@type":93},"Mia  ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-02","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is platinum resistance a major problem in ovarian cancer?","Question",{"text":112,"@type":113},"Platinum-based chemotherapy resistance is identified as a major clinical issue in ovarian cancers, creating an unmet need for predictive biomarkers and therapeutic strategies.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What does the paper evaluate regarding p73?",{"text":117,"@type":113},"It assesses the clinicopathological significance of p73 protein expression and the TP73 transcript level, including transcript analyses in public datasets and TCGA, and preclinical functional experiments in ovarian cancer cell models.",{"name":119,"@type":110,"acceptedAnswer":120},"How does p73 influence response to cisplatin?",{"text":121,"@type":113},"Preclinical results show p73 overexpression increases proliferation, invasion, spheroid formation, and DNA repair capacity, consistent with platinum resistance. In contrast, p73 deletion reduces proliferation and enhances cisplatin sensitivity through DNA double-strand break accumulation, G2/M arrest, and increased apoptosis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},370467,1790741648,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":46,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":31,"preview_page_count":19,"preview_urls":144},687207024478,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Article  \nTranscription Factor p73 Is a Predictor of Platinum Resistance and Promotes Aggressive Epithelial Ovarian Cancers  \nAhmed Shoqafi 1, Reem Ali 2, Ayat Lashen 1,3,†, Jennie N. Jeyapalan 1,4, Asmaa Ibrahim 3, Michael S. Toss 3, Emad A. Rakha 1,3, Mashael Algethami 1, Shatha Alqahtani 1, Nigel P. Mongan 1,4,5, Dindial Ramotar 2 and Srinivasan Madhusudan 1,6, *  \nAcademic Editor: Carmela Ricciardelli  \nReceived: 7 January 2025  \nRevised: 19 March 2025  \nAccepted: 25 March 2025  \nPublished: 31 March 2025  \nCitation: Shoqafi, A.; Ali, R.; Lashen, A.; Jeyapalan, J.N.; Ibrahim, A.; Toss, M.S.; Rakha, E.A.; Algethami, M.; Alqahtani, S.; Mongan, N.P.; et al. Transcription Factor p73 Is a Predictor of Platinum Resistance and Promotes Aggressive Epithelial Ovarian Cancers. Int. J. Mol. Sci. 2025, 26, 3239. [https://](https://)[ ](https://)[doi.org/10.3390/ijms26073239](doi.org/10.3390/ijms26073239)  \n[Copyright:](Copyright:) © 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://creativecommons.org/](https://creativecommons.org/)[ ](https://creativecommons.org/)[licenses/by/4.0/](licenses/by/4.0/)) .  \n1 Naaz Coker Ovarian Cancer Research Centre, Biodiscovery Institute, School of Medicine, University of Nottingham, University Park, Nottingham NG7 3RD, UK; [msxas29@exmail.nottingham.ac.uk](msxas29@exmail.nottingham.ac.uk) (A.S.); [mzxal1@exmail.nottingham.ac.uk](mzxal1@exmail.nottingham.ac.uk) (A.L.); [plzjnj@exmail.nottingham.ac.uk](plzjnj@exmail.nottingham.ac.uk) (J.N.J.); [mrzear1@exmail.nottingham.ac.uk](mrzear1@exmail.nottingham.ac.uk) (E.A.R.); [msxma58@exmail.nottingham.ac.uk](msxma58@exmail.nottingham.ac.uk) (M.A.); [mzxsa20@exmail.nottingham.ac.uk](mzxsa20@exmail.nottingham.ac.uk) (S.A.); [svznpm@exmail.nottingham.ac.uk](svznpm@exmail.nottingham.ac.uk) (N.P.M.)  \n2 Division of Biological and Biomedical Sciences, College of Health and Life Sciences, Hamad Bin Khalifa University, Education City, Qatar Foundation, Doha P.O. Box 34110, Qatar; [reaali@hbku.edu.qa](reaali@hbku.edu.qa) (R.A.); [dramotar@hbku.edu.qa](dramotar@hbku.edu.qa) (D.R.)  \n3 Department of Pathology, Nottingham University Hospitals, City Hospital Campus, Nottingham NG5 1PB, UK; [mzxai2@exmail.nottingham.ac.uk](mzxai2@exmail.nottingham.ac.uk) (A.I.); [msamt9@exmail.nottingham.ac.uk](msamt9@exmail.nottingham.ac.uk) (M.S.T.)  \n4 Centre for Cancer Sciences, University of Nottingham, Sutton Bonington Campus, Sutton Bonington, Leicestershire LE12 5RD, UK  \n5 Department of Pharmacology, Weill Cornell Medicine, New York, NY 10065, USA  \n6 Department of Oncology, Nottingham University Hospitals, City Hospital Campus, Nottingham NG5 1PB, UK  \n* Correspondence: [srinivasan.madhusudan@nottingham.ac.uk](srinivasan.madhusudan@nottingham.ac.uk)  \n† Current address: Cellular Pathology, St Marks Hospital, London NW10 7NS, UK.  \nAbstract: Resistance to platinum-based chemotherapy is a major clinical problem in ovarian cancers. The development of predictive biomarkers and therapeutic approaches is an area of unmet need. p73, a member of the p53 family of transcription factors, has essential functions during DNA repair, proliferation, invasion, and apoptosis. The role of p73 in ovarian cancer pathogenesis and response to therapy is largely unknown. The clinicopathological significance of p73 protein expression was evaluated in 278 human ovarian cancers. TP73 transcripts were investigated in publicly available clinical data sets (n = 522) and bioinformatics analysis was completed in the ovarian TCGA cohort (n = 182) . Preclinically, p73 was overexpressed in A2780 platinum-sensitive ovarian cancer cells or depleted in platinum-resistant A2780cis cells and investigated for aggressive phenotypes, as well as platinum sensitivity. High p73 protein expression was linked with high grade (p \u003C 0.001), advanced-stage disease (p = 0.002), and ","cbCaioAH1fErQq8Q","https://ap.wps.com/l/cbCaioAH1fErQq8Q","pdf",23948926,"English","# Introduction\n## p73 in the p53 family of transcription factors\n## p73 functional domains and isoforms\n## Genomic location and relevance to ovarian cancer\n# Materials and Methods\n# Results\n# Discussion\n# Conclusions","[{\"question\":\"Why is platinum resistance a major problem in ovarian cancer?\",\"answer\":\"Platinum-based chemotherapy resistance is identified as a major clinical issue in ovarian cancers, creating an unmet need for predictive biomarkers and therapeutic strategies.\"},{\"question\":\"What does the paper evaluate regarding p73?\",\"answer\":\"It assesses the clinicopathological significance of p73 protein expression and the TP73 transcript level, including transcript analyses in public datasets and TCGA, and preclinical functional experiments in ovarian cancer cell models.\"},{\"question\":\"How does p73 influence response to cisplatin?\",\"answer\":\"Preclinical results show p73 overexpression increases proliferation, invasion, spheroid formation, and DNA repair capacity, consistent with platinum resistance. In contrast, p73 deletion reduces proliferation and enhances cisplatin sensitivity through DNA double-strand break accumulation, G2/M arrest, and increased apoptosis.\"}]","Transcription Factor p73 Is a Predictor of Platinum Resistance and Promotes Aggressive Epithelial Ovarian Cancers | PDF",1790188686,[145,149,153,157],{"page_no":8,"url":146,"width":147,"height":148},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e973a2853e782c0f4e79bce0532923b3.webp",983,1390,{"page_no":14,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/99ee0a464a2267675669f760527494e7.webp",982,1388,{"page_no":81,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d36c5d0d4162a6b8b4a0078adeeea04e.webp",981,1387,{"page_no":19,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7dff85a6c22016e1c1cf6e5b7c66f073.webp",980,1385]